Internal carotid artery patency after mechanical thrombectomy for stroke due to occlusive dissection: Impact on outcome.


Journal

European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446

Informations de publication

Date de publication:
03 2023
Historique:
received: 29 09 2022
accepted: 04 11 2022
medline: 7 4 2023
entrez: 6 4 2023
pubmed: 7 4 2023
Statut: ppublish

Résumé

Internal carotid artery dissection (ICAD) is a rare cause of acute ischemic stroke with large vessel occlusion (AIS-LVO). We aimed investigating the impact on outcome of internal carotid artery (ICA) patency after mechanical thrombectomy (MT) for AIS-LVO due to occlusive ICAD. We included consecutive patients with AIS-LVO due to occlusive ICAD treated with MT from January 2015 to December 2020 in three European stroke centers. We excluded patients with unsuccessful intracranial reperfusion after MT (modified Thrombolysis in Cerebral Infarction (mTICI) score < 2b). We compared 3-month favorable clinical outcome rate, defined as a modified Rankin scale (mRS) score ⩽2, according to ICA status (patency vs occlusion) at the end of MT and at 24-h follow-up imaging, using univariate and multivariable models. Among 70 included patients, ICA was patent in 54/70 (77%) at the end of MT, and in 36/66 (54.5%) patients with 24-h follow-up imaging. Among patients with ICA patency at the end of MT, 32% presented ICA occlusion at 24-h control imaging. Favorable 3-month outcome occurred in 41/54 (76%) patients with ICA patency post-MT and in 9/16 (56%) patients with occluded ICA post-MT ( Obtaining sustained (24-h) ICA patency after MT could be a therapeutic target for improving functional outcome in patients with AIS-LVO due to ICAD.

Identifiants

pubmed: 37021179
doi: 10.1177/23969873221140649
pii: 10.1177_23969873221140649
pmc: PMC10069197
doi:

Types de publication

Journal Article

Langues

eng

Pagination

199-207

Informations de copyright

© European Stroke Organisation 2022.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

JACC Cardiovasc Interv. 2018 Jul 9;11(13):1290-1299
pubmed: 29976365
Stroke. 2018 Oct;49(10):2520-2522
pubmed: 30355119
Interv Neurol. 2013 Sep;1(3-4):164-70
pubmed: 25187776
Stroke. 2004 Feb;35(2):482-5
pubmed: 14757894
J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1697-701
pubmed: 15548485
Int J Stroke. 2021 Apr;16(3):342-348
pubmed: 32515696
Cerebrovasc Dis. 2016;42(3-4):272-9
pubmed: 27199235
Neurology. 2020 Jan 14;94(2):e170-e180
pubmed: 31757869
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Neurology. 2002 Jul 9;59(1):26-33
pubmed: 12105303
Eur Stroke J. 2017 Jun;2(2):95-102
pubmed: 29900406
Int J Stroke. 2018 Aug;13(6):612-632
pubmed: 29786478
Neurol Res Pract. 2021 May 3;3(1):20
pubmed: 33934710
Eur Stroke J. 2021 Sep;6(3):XXXIX-LXXXVIII
pubmed: 34746432
J Stroke. 2021 Sep;23(3):411-419
pubmed: 34649385
Neurology. 2018 Aug 21;91(8):e769-e780
pubmed: 30068628
Neurology. 2021 Aug 3;97(5):e444-e453
pubmed: 34162721
Stroke. 2020 Dec;51(12):3713-3718
pubmed: 33167809
Lancet. 2014 Nov 29;384(9958):1929-35
pubmed: 25106063
Eur J Neurol. 2013 Nov;20(11):1431-9
pubmed: 23837733
Cerebrovasc Dis. 2008;25(5):457-507
pubmed: 18477843
J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1528-33
pubmed: 16227545
Neuroradiology. 2016 Dec;58(12):1167-1179
pubmed: 27796447
Eur J Neurol. 2021 Aug;28(8):2736-2744
pubmed: 33960072
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Stroke. 2013 Aug;44(8):2324-6
pubmed: 23686975
J Neuroradiol. 2019 Nov;46(6):373-377
pubmed: 30772368
Stroke. 2009 Dec;40(12):3772-6
pubmed: 19834022
N Engl J Med. 2008 Sep 25;359(13):1317-29
pubmed: 18815396
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
J Neurol. 2022 Feb;269(2):772-779
pubmed: 34184125

Auteurs

Giuseppe Scopelliti (G)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.

Arnaud Karam (A)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
Department of Neuroradiology, Roger Salengro Hospital, CHU Lille, University of Lille, Lille, France.

Julien Labreuche (J)

Department of Biostatistics, CHU Lille, Lille, France.

Nicolas Bricout (N)

Department of Neuroradiology, Roger Salengro Hospital, CHU Lille, University of Lille, Lille, France.

Federico Marrama (F)

Department of Systems Medicine, University of Tor Vergata, Rome, Italy.

Marina Diomedi (M)

Department of Systems Medicine, University of Tor Vergata, Rome, Italy.

Wagih Ben Hassen (W)

Department of Neuroradiology, GHU Paris, Université de Paris, INSERM UMR 1266, Paris, France.

Xavier Leclerc (X)

Department of Neuroradiology, Roger Salengro Hospital, CHU Lille, University of Lille, Lille, France.

Charlotte Cordonnier (C)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.

Hilde Henon (H)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.

Barbara Casolla (B)

Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
UR2CA-URRIS, Stroke Unit, CHU Pasteur 2, Nice Cote d'Azur University, Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH